Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 13;13(12):2355.
doi: 10.3390/genes13122355.

Genetic Variants and Protective Immunity against SARS-CoV-2

Affiliations
Review

Genetic Variants and Protective Immunity against SARS-CoV-2

Ali A Rabaan et al. Genes (Basel). .

Abstract

The novel coronavirus-19 (SARS-CoV-2), has infected numerous individuals worldwide, resulting in millions of fatalities. The pandemic spread with high mortality rates in multiple waves, leaving others with moderate to severe symptoms. Co-morbidity variables, including hypertension, diabetes, and immunosuppression, have exacerbated the severity of COVID-19. In addition, numerous efforts have been made to comprehend the pathogenic and host variables that contribute to COVID-19 susceptibility and pathogenesis. One of these endeavours is understanding the host genetic factors predisposing an individual to COVID-19. Genome-Wide Association Studies (GWAS) have demonstrated the host predisposition factors in different populations. These factors are involved in the appropriate immune response, their imbalance influences susceptibility or resistance to viral infection. This review investigated the host genetic components implicated at the various stages of viral pathogenesis, including viral entry, pathophysiological alterations, and immunological responses. In addition, the recent and most updated genetic variations associated with multiple host factors affecting COVID-19 pathogenesis are described in the study.

Keywords: COVID-19; Genetic resistance; coronaviruses; protective immunity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Genetic resistance of host against the COVID-19 virus at the level of entry of the virus.
Figure 2
Figure 2
Genetic components responsible for immune response.

Similar articles

Cited by

References

    1. Bastard P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.-H., Zhang Y., Dorgham K., Philippot Q., Rosain J., Béziat V., et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585. - DOI - PMC - PubMed
    1. Zhang Q., Bastard P., Bolze A., Jouanguy E., Zhang S.-Y., Cobat A., Notarangelo L.D., Su H.C., Abel L., Casanova J.-L. Life-Threatening COVID-19: Defective Interferons Unleash Excessive Inflammation. Med. 2020;1:14–20. doi: 10.1016/j.medj.2020.12.001. - DOI - PMC - PubMed
    1. Cerami C., Popkin-Hall Z.R., Rapp T., Tompkins K., Zhang H., Muller M.S., Basham C., Whittelsey M., Chhetri S.B., Smith J., et al. Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in the United States: Living Density, Viral Load, and Disproportionate Impact on Communities of Color. Clin. Infect. Dis. 2022;74:1776–1785. doi: 10.1093/cid/ciab701. - DOI - PMC - PubMed
    1. Madewell Z.J., Yang Y., Longini I.M., Halloran M.E., Dean N.E. Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis. JAMA Netw. Open. 2020;3:e2031756. doi: 10.1001/jamanetworkopen.2020.31756. - DOI - PMC - PubMed
    1. Reukers D.F.M., van Boven M., Meijer A., Rots N., Reusken C., Roof I., van Gageldonk-Lafeber A.B., van der Hoek W., van den Hof S. High Infection Secondary Attack Rates of Severe Acute Respiratory Syndrome Coronavirus 2 in Dutch Households Revealed by Dense Sampling. Clin. Infect. Dis. 2022;74:52–58. doi: 10.1093/cid/ciab237. - DOI - PMC - PubMed